IONSbenzinga

JP Morgan Maintains Neutral on Ionis Pharmaceuticals, Raises Price Target to $48

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on June 12, 2025 by benzinga